| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.08 | 0.04 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.04 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.098 | 0.04 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.05 |